Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Antiviral Res. 2009 Mar 10;82(3):169–171. doi: 10.1016/j.antiviral.2009.02.201

Figure 3.

Figure 3

Brain titers of C57BL/6 mice infected with WEEV and treated twice a day for 7 days with T-705 administered orally at a dose of 400 mg/kg/d. Lines represent mean titers for each group (P = 0.3287 as determined by one-way Student’s t-test).